HIV Mutation Detail Information

> Y181C Search Result

Mutation Information

Mutation Site	Y181C
Mutation Type	Amino acid level
Gene/Protein/Region Type	RT
Relevant Drug	NNRTIs
Country	italy

Literature Information

PubMed PMID	27858889
Disease	HBV-HCV-HIV coinfection; HIV-HBV coinfection; HIV-HCV coinfection
Published Year	2016
Journal	Medicine
Title	Correlates of infection and molecular characterization of blood-borne HIV, HCV, and HBV infections in HIV-1 infected inmates in Italy: An observational cross-sectional study.
Author	Sanarico N,D'Amato S,Bruni R,Rovetto C,Salvi E,Di Zeo P,Chionne P,Madonna E,Pisani G,Costantino A,Equestre M,Tosti ME,Cenci A,Maggiorella MT,Sernicola L,Pontali E,Pansera A,Quattrocchi R,Carbonara S,Signorile F,Surace LA,Federzoni G,Garlassi E,Starnini G,Monarca R,Babudieri S,Rapicetta M,Pompa MG,Caraglia A,Ensoli B,Ciccaglione AR,Buttò S
Evidence	Variants carrying the K103N and Y181C resistance mutations to non-nucleoside reverse transcriptase inhibitors (NNRTIs) were found in 2 out of 9 patients naive for combined antiretroviral therapy (cART) (22.2%).

Contents
Description

Mutation Information Note

Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)

Literature Information Note

Evidence: sentence contains this mutation information in the citation